In the ever-evolving landscape of diabetes management, physicians are often faced with decisions that require balancing potential benefits with possible risks. Recently, a dedicated family doctor was in a situation of uncertainty regarding the prescription of Empagliflozin for a patient with type 2 diabetes. Despite constant efforts with diet maintenance and exercise, the patient’s blood sugar levels remained just as high. Empagliflozin, known for its effectiveness in controlling blood sugar, is seen to be a promising option. However, the family doctor does not know if he can prescribe this type of medication.
Seeking guidance from Diabeta
In search of clarity and reassurance, the doctor turned to Diabeta, a reliable platform that provides specialized information on diabetes management. This innovative resource processes information from official diabetes guidelines and protocols.
The answer provided by Diabeta highlights the fact that Empagliflozin can be prescribed to a patient only by the diabetologist or other diabetologist specialists, based on the therapeutic protocol and the guide in force. The family doctor can continue to prescribe this medicine only in doses and for the period indicated by the medical referral letter issued by the diabetologist specialist, in accordance with the treatment protocols and guidelines.
Fast and correct response
Using Diabeta, the family doctor received a clear and complex answer to the question asked in a short time. The answer provided by Diabeta is a correct, informed and up-to-date response, based on information from diabetes protocols and guidelines. With the help of this tool, the family doctor can carry out his work without uncertainties in terms of drug prescription, but also much more.
Join Diabeta`s community today!
Have you experienced similar support from Diabeta? Together, we can continue to improve diabetes management and patient outcomes.
DIABETA has benefited from the support of prestigious partners, such as Novo Nordisk, Boehringer Ingelheim and Medtronic. This partnership shows how a local initiative can achieve a global impact, bringing together resources and experiences to address diabetes-related challenges.
